Literature DB >> 2963331

Activation of a preexisting cellular factor as a basis for adenovirus E1A-mediated transcription control.

R Reichel1, I Kovesdi, J R Nevins.   

Abstract

Transcription of the set of early adenovirus genes is subject to positive control by the viral E1A gene. For one early viral gene, the E2 gene, this induction involves an increase in a cellular promoter-specific factor termed E2F. We have analyzed the kinetics for this induction and find that E2F is present at only very low levels in extracts of uninfected cells or cells infected for up to 3 hr with adenovirus type 5. The factor increases rapidly at 5 hr and reaches a maximal level at 7-8 hr. The kinetics of induction of the factor are thus coincident with the induction of E2 transcription. The 13S E1A gene product (289-amino acid protein), which is required for the efficient activation of E2 transcription in a productive infection, is also responsible for the activation of E2F, because infection with mutant strain pm975 (13S+, 12S-) induces the factor, whereas no increase of E2F occurs in cells infected by mutant strain dl1500 (13S-, 12S+). Finally, increase in the factor does not involve synthesis of any new protein, because extracts prepared from cells infected with adenovirus type 5 and treated with cycloheximide from 1 hr after infection contain approximately the same level of E2F as extracts from infected but untreated cells. From these results, we conclude that activation of E2F, as a posttranslational event, is responsible for the stimulation of E2 transcription by E1A.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2963331      PMCID: PMC279553          DOI: 10.1073/pnas.85.2.387

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Transcription of class III genes activated by viral immediate early proteins.

Authors:  R B Gaynor; L T Feldman; A J Berk
Journal:  Science       Date:  1985-10-25       Impact factor: 47.728

2.  Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses.

Authors:  M Perricaudet; G Akusjärvi; A Virtanen; U Pettersson
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

3.  The E4 transcriptional unit of Ad2: far upstream sequences are required for its transactivation by E1A.

Authors:  P Gilardi; M Perricaudet
Journal:  Nucleic Acids Res       Date:  1984-10-25       Impact factor: 16.971

4.  Enhancement of RNA polymerase III transcription by the E1A gene product of adenovirus.

Authors:  W K Hoeffler; R G Roeder
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

5.  Mechanism of activation of early viral transcription by the adenovirus E1A gene product.

Authors:  J R Nevins
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

6.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

Authors:  A J Berk; F Lee; T Harrison; J Williams; P A Sharp
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

7.  Complete transformation by adenovirus 2 requires both E1A proteins.

Authors:  C Montell; G Courtois; C Eng; A Berk
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  Expression of early adenovirus genes requires a viral encoded acidic polypeptide.

Authors:  R P Ricciardi; R L Jones; C L Cepko; P A Sharp; B E Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Regulation of the primary expression of the early adenovirus transcription units.

Authors:  J R Nevins; H S Ginsberg; J M Blanchard; M C Wilson; J E Darnell
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

10.  Dissection of overlapping functions within the adenovirus type 5 E1A gene.

Authors:  G Winberg; T Shenk
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

View more
  40 in total

1.  Timely synthesis of the adenovirus type 5 E1B 55-kilodalton protein is required for efficient genome replication in normal human cells.

Authors:  Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system.

Authors:  S Bagchi; P Raychaudhuri; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor.

Authors:  S W Hiebert; M Lipp; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding.

Authors:  A S Yee; P Raychaudhuri; L Jakoi; J R Nevins
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

5.  The cellular transcription factor E2f requires viral E1A and E4 gene products for increased DNA-binding activity and functions to stimulate adenovirus E2A gene expression.

Authors:  L E Babiss
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

6.  The adenovirus E4 gene, in addition to the E1A gene, is important for trans-activation of E2 transcription and for E2F activation.

Authors:  R Reichel; S D Neill; I Kovesdi; M C Simon; P Raychaudhuri; J R Nevins
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Role of E2F transcription factor in E1A-mediated trans activation of cellular genes.

Authors:  S W Hiebert; M Blake; J Azizkhan; J R Nevins
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 8.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

9.  Cyclic AMP induction of early adenovirus promoters involves sequences required for E1A trans-activation.

Authors:  P Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

Review 10.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.